The NIH HEAL Initiative is offering this grant to advance device-based pain relief solutions. Over 25 million Americans experience chronic pain, historically leading to opioid over-prescription and a devastating addiction epidemic. There is a critical need for innovative, non-addictive pain treatments. This grant is specifically designed to support interdisciplinary research teams investigating the mechanisms of action for FDA-approved or -cleared device-based pain relief technologies. The overarching goal is to optimize therapeutic outcomes for patients. Teams are expected to foster considerable synergy and leverage multidisciplinary expertise to develop new experimental principles and methods, driving major advances in device-based pain relief. This grant is for this purpose: to accelerate the development and understanding of safe, effective alternative pain management options.
Opportunity ID: 335512
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-NS-22-016 |
Funding Opportunity Title: | HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief (RM1 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Aug 31, 2021 |
Last Updated Date: | Aug 31, 2021 |
Original Closing Date for Applications: | Nov 03, 2021 |
Current Closing Date for Applications: | Nov 03, 2021 |
Archive Date: | Dec 09, 2021 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Special district governments County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | More than 25 million Americans suffer from daily chronic pain, a highly debilitating medical condition that is complex and difficult to manage. In recent decades, there has been an overreliance in the prescription of opioids for chronic pain despite their poor ability to improve function and high addiction liability. This contributed to a significant and alarming epidemic of opioid overdose deaths and addictions. Innovative scientific solutions to develop alternative pain treatment options are thus critically needed. Through targeted research efforts, the NIH HEAL Initiative aims to support the development of safe and effective devices to treat pain with little or no addiction liability. This funding opportunity announcement (FOA) is designed to support interdisciplinary research teams of multiple PD/PIs to investigate the mechanism of action of device-based pain relief with the overall goal of optimizing therapeutic outcomes for FDA-approved or -cleared technologies. Program teams are expected to accomplish goals that require considerable synergy and collaborative interactions. Teams must leverage appropriate multi-disciplinary expertise to develop new principles and methods for experimentation, analysis, and interpretation. Teams are encouraged to consider objectives that will produce major advances in the field of device-based pain relief. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-016.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268757 | Oct 03, 2021 | Jan 24, 2022 | View |
Package 1
Mandatory forms
335512 RR_SF424_2_0-2.0.pdf
335512 PHS398_CoverPageSupplement_5_0-5.0.pdf
335512 RR_OtherProjectInfo_1_4-1.4.pdf
335512 PerformanceSite_2_0-2.0.pdf
335512 RR_KeyPersonExpanded_2_0-2.0.pdf
335512 RR_Budget_1_4-1.4.pdf
335512 PHS398_ResearchPlan_4_0-4.0.pdf
335512 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
335512 RR_SubawardBudget30_1_4-1.4.pdf
335512 PHS_AssignmentRequestForm_3_0-3.0.pdf